Dr. Nirav Niranjan Shah explains the data behind why autologous stem cell transplant should remain the standard of care for patients with relapsed chemo-sensitive DLBCL.
Nirav Niranjan Shah, MD
Advertisement
Articles by Nirav Niranjan Shah, MD
Advertisement
Latest Updated Articles
Autologous Stem Cell Transplant Should Remain Standard of Care for Certain DLBCL Patients, Expert SaysPublished: June 9th 2020 | Updated:
Advertisement
Advertisement
Trending on CURE
1
‘Full House’ Star Dave Coulier Talks Tongue Cancer Diagnosis
2
Rybrevant Faspro FDA-Approved as First Sub-Q Therapy for EGFR NSCLC
3
Stage 4 Pancreatic Cancer Survivor Shares Clinical Trial Path
4
New Approach May Offer Stronger Treatment Effects in Metastatic Breast Cancer
5